3,4-dihydrocoumarin has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
melilotol: structure in first source
3,4-dihydrocoumarin : A chromanone that is the 3,4-dihydro derivative of coumarin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, L | 1 |
| Chen, Y | 1 |
| Zeng, RF | 1 |
| Liu, Y | 1 |
| Xie, SS | 1 |
| Lan, JS | 1 |
| Ding, Y | 1 |
| Yang, YT | 1 |
| Yang, J | 1 |
| Zhang, T | 1 |
1 other study available for 3,4-dihydrocoumarin and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Design and synthesis of novel 3,4-dihydrocoumarins as potent and selective monoamine oxidase-B inhibitors with the neuroprotection against Parkinson's disease.
Topics: Animals; Coumarins; Drug Design; Indans; Mice; Models, Molecular; Molecular Structure; Monoamine Oxi | 2021 |